CD19 and carcinoma: For carcinomas, immunohistochemistry was performed in seven cases; two adenocarcinomas had both CD19 and CA 19-9 positivity, with CD10, S100, P53, CAIX positivity, and vimentin, tyrosine-kinase, and CD56 negativity in one case.